stars 1 stars 2 stars 3

FutureChem was founded in 1999 and is headquartered in Seoul, South Korea. The company offers to produce and sells radiopharmaceuticals for diagnosing cancers, and Parkinson's and Alzheimer's diseases; and automation modules and disposable goods, such as disposable cassettes, reagent kits, and Radio-Caps. It also provides peptide-based radiopharmaceuticals for radio-metal chelation and click reaction; linkers for bio-conjugation using copper-free/mediated click reaction; fluorinated compounds; and custom synthesis services, as well as develops and produces precursors and chemicals of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals. In addition, the company is involved in the research and development of radioisotope labeling technology, development of PET radiopharmaceuticals, theranostics, active pharmaceutical ingredients and automation devices, as well as performs government research project and academic-industrial collaboration services.

FutureChem Questions

The FutureChem annual revenue was $5.1 million in 2026.

Jeseung Hwang is the Director of Sales Marketing of FutureChem.

4 people are employed at FutureChem.

The NAICS codes for FutureChem are [32541, 325, 32, 3254].

The SIC codes for FutureChem are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users